Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 22.
doi: 10.1245/s10434-022-11454-y. Online ahead of print.

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

Lan-Qing Yao  1 , Zheng-Liang Chen  2 , Zi-Han Feng  3 , Yong-Kang Diao  4 , Chao Li  1 , Hai-Ying Sun  1 , Jian-Hong Zhong  5 , Ting-Hao Chen  6 , Wei-Min Gu  7 , Ya-Hao Zhou  8 , Wan-Guang Zhang  9 , Hong Wang  10 , Yong-Yi Zeng  11 , Han Wu  1 , Ming-Da Wang  1 , Xin-Fei Xu  1 , Timothy M Pawlik  12 , Wan Yee Lau  1   13 , Feng Shen  14 , Tian Yang  15   16
Affiliations

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

Lan-Qing Yao et al. Ann Surg Oncol. .

Erratum in

Abstract

Background: A potentially curative hepatic resection is the optimal treatment for hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur after resection. This study investigates clinical features of initial recurrence and long-term prognosis of patients with recurrence after curative resection for early-stage HCC.

Patients and methods: From a multicenter database, patients who underwent curative hepatic resection for early-stage HCC [Barcelona Clinic Liver Cancer (BCLC) stage 0/A] were extracted. Time to initial recurrence, patterns of initial recurrence, and treatment modalities for recurrent tumors were investigated. Univariate and multivariate analysis were used to identify independent risks associated with postoperative recurrence, as well as post-recurrence survival (PRS) for patients with recurrence.

Results: Among 1424 patients, 679 (47.7%) developed recurrence at a median follow-up of 54.8 months, including 408 (60.1%) early recurrence (≤ 2 years after surgery) and 271 (39.9%) late recurrence (> 2 years). Independent risks of postoperative recurrence included cirrhosis, preoperative alpha-fetoprotein level > 400 ug/L, tumor size > 5 cm, multiple tumors, satellites, microvascular invasion, and intraoperative blood transfusion. Multivariate analysis revealed that receiving irregular recurrence surveillance, initial tumor beyond Milan criteria, early recurrence, BCLC stage B/C of the recurrent tumor, and noncurative treatments were independently associated with poorer PRS.

Conclusions: Nearly half of patients with early-stage HCC experienced recurrence after resection. Understanding recurrence risks may help identify patients at high risk of recurrence who may benefit from future adjuvant therapies. Meaningful survival even after recurrence can still be achieved by postoperative regular surveillance and curative treatment.

PubMed Disclaimer

References

    1. Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7(1):6. - DOI - PubMed
    1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. - DOI - PubMed
    1. Yang T, Lu JH, Wu MC. Hepatocellular carcinoma in China. BMJ. 2010;340:C1026. - DOI
    1. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the Bclc staging classification. Semin Liver Dis. 1999;19(3):329–38. - DOI - PubMed
    1. Fuster J. Surgical treatment of hepatocellular carcinoma: should resection be performed according to barcelona clinic liver cancer classification. Hepat Oncol. 2015;2(3):245–53. - DOI - PubMed - PMC

LinkOut - more resources